Polymyxin B Attenuates Sepsis‐Induced Acute Kidney Injury by Activating a SUMO1‐p65 “Molecular Brake” in Kidney Organoids
Cell Biology International · 2026-10 · 50 (10)
DOI: 10.1002/cbin.70209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 28.09.2026. Verfasst von Qing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Tianjin Fifth Central Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Sepsis, SUMO-1 Protein, Polymyxin B, Transcription Factor RelA. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Science and Technology Project of Binhai New Area Health Commission, Tianjin Municipal Health Commission, Joint Funds of the Natural Science Foundation of Tianjin.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐induced acute kidney injury (SAKI) is a deadly complication in critical care, driven by a devastating inflammatory surge and loss of renal parenchymal integrity. While polymyxin B (PMB) is traditionally utilized as a last‐resort antibiotic, emerging evidence suggests it possesses non‐canonical immunomodulatory properties that remain mechanistically elusive. This study investigated the intracellular post‐translational modification (PTM) pathways through which PMB mitigates renal inflammation. We employed a dual‐model approach utilizing 3D mouse kidney organoids and SUMO1 −/− mouse models to examine the genetic dependency of PMB‐mediated renoprotection. Transcriptomic profiling revealed that PMB robustly suppresses NF‐κB ‐driven inflammatory programs in wild‐type (WT) organoids, specifically reducing the expression of Cxcl1 and Il6 . In contrast, this anti‐inflammatory efficacy was abrogated in SUMO1‐deficient models, where the pharmacological response shifted toward metabolic pathways, such as cholesterol metabolism. Mechanistically, PMB promotes SUMO1 conjugation to the NF‐κB p65 subunit, functioning as a “molecular brake” that limits p65 hyperphosphorylation and transcriptional activation. Together, these results identify the SUMO1‐p65 axis constitutes a pivotal regulatory checkpoint for PMB‐mediated immunomodulation. This study establishes a novel therapeutic paradigm by underscoring the promise of targeting PTM pathways to alleviate septic organ dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, Tianjin Fifth Central Hospital, Tianjin, China.
- Department of Emergency Medicine, Tianjin Fifth Central Hospital, Tianjin, China.
- Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin Fifth Central Hospital, Tianjin, China.
- Emergency Medicine Research Institute, Tianjin Fifth Central Hospital, Tianjin, China.
- School of Medicine, Tianjin University, Tianjin, China.
ORCID-Profile: Na Xue, Yanxia Li, Xiyun Bian, Xiaoming Hou
Förderung
- Science and Technology Project of Binhai New Area Health Commission
- Tianjin Municipal Health Commission
- Joint Funds of the Natural Science Foundation of Tianjin
- Tianjin Key Medical Discipline Construction Project
- National Key Specialty Construction Project
- Tianjin Natural Science Foundation
- Natural Science Foundation of Tianjin City
Zitieren
APA
Wang, Q., Xue, N., Yu, T., Li, Y., Bian, X., Hou, X., Dou, L., Feng, Q., & Liu, X. (2026). Polymyxin B Attenuates Sepsis‐Induced Acute Kidney Injury by Activating a SUMO1‐p65 “Molecular Brake” in Kidney Organoids. Cell Biology International, 50(10). https://doi.org/10.1002/cbin.70209
Vancouver
Wang Q, Xue N, Yu T, Li Y, Bian X, Hou X, et al. Polymyxin B Attenuates Sepsis‐Induced Acute Kidney Injury by Activating a SUMO1‐p65 “Molecular Brake” in Kidney Organoids. Cell Biology International. 2026;50(10). doi:10.1002/cbin.70209
BibTeX
@article{Wang2026,
author = {Wang, Qing and Xue, Na and Yu, Tian and Li, Yanxia and Bian, Xiyun and Hou, Xiaoming and Dou, Lin and Feng, Qingguo and Liu, Xiaozhi},
title = {Polymyxin B Attenuates Sepsis‐Induced Acute Kidney Injury by Activating a SUMO1‐p65 “Molecular Brake” in Kidney Organoids},
journal = {Cell Biology International},
year = {2026},
volume = {50},
number = {10},
doi = {10.1002/cbin.70209}
}
EUVIMED